Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 4.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 4.45% | |||
| Cost of Revenue | 0.32% | -15.10% | |||
| Gross Profit | 0.32% | 15.81% | |||
| SG&A Expenses | 0.32% | 21.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.32% | 16.40% | |||
| Total Operating Expenses | 0.32% | 3.39% | |||
| Operating Income | -0.32% | 1.39% | |||
| Income Before Tax | -0.32% | 6.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.32% | 6.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | 6.23% | |||
| EBIT | -0.32% | 1.39% | |||
| EBITDA | -0.32% | -121.93% | |||
| EPS Basic | 0.00% | 11.36% | |||
| Normalized Basic EPS | 0.00% | 14.29% | |||
| EPS Diluted | 0.00% | 11.36% | |||
| Normalized Diluted EPS | 0.00% | 14.29% | |||
| Average Basic Shares Outstanding | 0.00% | 7.56% | |||
| Average Diluted Shares Outstanding | 0.00% | 7.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||